Skip to content
Fundamentalis
Fundamentalis
Insightful market commentary from a fresh perspective.
  • Home
  • About Brian
  • Trinity Asset Management

Category: Biotech

HealthCare Sector: Growth Has Been Healthy, But Will Sector P.E Compress in Presidential Election Year ?

November 23, 2015 Brian Gilmartin Leave a comment

The HealthCare sector has struggled since the August ’15, China-induced, beat down on the major equity indices, which is exactly…

Continue Reading →

Posted in: Apple (AAPL), Biotech, Health Care sector, MRK, PFE

Is SP 500 Market Leadership Changing ?

October 6, 2015 Brian Gilmartin Leave a comment

Apple and biotech’s, the SP 500’s leadership for years, is what you should be keeping an eye on. The weakness…

Continue Reading →

Posted in: Apple (AAPL), Biotech, Biotech sector / earnings, Emerging Markets, Energy sector

SP 500 Earnings Update: Sell Health Care, Buy Energy ?

September 26, 2015 Brian Gilmartin Leave a comment

By next Friday, October 2nd, 2015, readers will know what the September ’15 jobs report looked like, and what the…

Continue Reading →

Posted in: Biotech, Biotech sector / earnings, Energy sector, Health Care sector, S&P 500, Weekly Earnings Update

Wondering if SP 500 Leadership Groups Are Now Breaking Down and Why Won’t Interest Rates Rise ?

August 6, 2015 Brian Gilmartin Leave a comment

Nothing like a blog post that solves all the world’s problems in 500 words or less. Even the most skeptical…

Continue Reading →

Posted in: Apple (AAPL), Biotech

10.5.14: More on SP 500 Earnings and a Look at Revenue Estimates by Sector

October 5, 2014 Brian Gilmartin Leave a comment

Our primary source of earnings data is Thomson Reuters, both the weekly “This Week in Earnings” and the intermittent emails,…

Continue Reading →

Posted in: Biotech, Financial sector, Financials, Gilead, MSFT, S&P 500, SP 500 Revenue Growth

Post navigation

Page 3 of 4
← Previous 1 2 3 4 Next →

Fundamentalis

  • Bond / Fixed-Income Returns Having a Good Year (so far) in 2025
  • SP 500 Earnings: SP 500 EPS Growth for 2025 Has Risen from 8% to 10% since Late June
  • Walmart Post-Earnings: Noisy Quarter, but Operationally, Walmart is Fine
  • Walmart Earnings Preview: Tariffs, Trade Policy Have Complicated Picture; Focus on the Operating Margin
  • Cisco is Fine Post Earnings: Cisco and IBM Might be the “Anti-AI” Tech Stocks

Subscribe to Fundamentalis

Loading

Archives

Copyright © 2025 Fundamentalis